EUVIMEDEUVIMED entdecken
Crossref

Assessing Acute and Long‐Term Toxicities of Proton Radiation Therapy in Pediatric Pelvic Tumors: Findings From the Pediatric Proton Consortium Registry

Jamil Almohtasib iD, Daniel J Indelicato iD, Arnold C Paulino iD, Stephen Mihalcik, Jae Lee, Ralph Ermoian iD, John Hah-Chih Chang iD, Young Kwok, John Perentesis, Stephanie M Perkins, Christine Hill-Kayser, Wael Zeina und 3 weitere

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31811 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Jamil Almohtasib und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Proton Therapy, Pelvic Neoplasms, Registries, Radiation Injuries. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: NCI NIH HHS, Proton Therapy Research and Treatment Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Proton beam therapy (PT) offers a targeted approach to treating pediatric tumors by minimizing radiation exposure to surrounding healthy tissue. However, the specific toxicity profile associated with it remains underexplored. This study aims to investigate the incidence and risk factors of acute and late treatment‐related toxicities following PT in pediatric patients with pelvic tumors.

Methods

Using data from the Pediatric Proton Consortium Registry (PPCR), we analyzed 126 pediatric patients who underwent PT for pelvic tumors. We assessed the incidence of gastrointestinal (GI), genitourinary (GU), and musculoskeletal (MSK) toxicities at baseline, during treatment, and across follow‐up intervals.

Results

Acute toxicities were observed in 61.9% of patients posttreatment, with new GI, GU, and MSK toxicities occurring in 54.3%, 9.7%, and 7.0% of baseline toxicity‐free patients, respectively. Follow‐up indicated that 20.6%, 22.2%, and 13.5% of patients developed late GI, GU, and MSK toxicities, respectively. Use of passive scattering proton therapy and radiation to the abdomen were significant predictors of GI toxicity development, while higher radiation dose was associated with MSK toxicity development.

Conclusion

Our findings demonstrate the safety profile of PT among pediatric patients while identifying specific risk factors, such as passive scattering proton therapy and abdominal irradiation, that contribute to increased GI toxicity. While proton therapy appears to be a well‐tolerated treatment option, the observed toxicity rates highlight the need for continued monitoring and long‐term follow‐up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton TherapyPelvic NeoplasmsRegistriesRadiation InjuriesHumansChildFemaleMaleChild, PreschoolAdolescentFollow-Up StudiesInfantIncidenceRisk FactorsPrognosis

Stichwörter der Autor:innen

Pediatric oncologyproton therapyradiation toxicity

Autor:innen und Institutionen

  • Department of Urology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Radiation Oncology, University of Florida, Jacksonville, Florida, USA.
  • Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Northwestern Medicine Chicago Proton Center, Warrenville, Illinois, USA.
  • Department of Radiation Oncology, ProCure Proton Therapy Center, Franklin Township, New Jersey, USA.
  • Department of Radiation Oncology, University of Washington, Seattle, Washington, USA.

ORCID-Profile: Jamil Almohtasib, Daniel J Indelicato, Arnold C Paulino, Ralph Ermoian, John Hah-Chih Chang, Nadia N Laack, Torunn I Yock

Förderung

  • NCI NIH HHS
  • Proton Therapy Research and Treatment Center

Zitieren

APA

Almohtasib, J., Indelicato, D. J., Paulino, A. C., Mihalcik, S., Lee, J., Ermoian, R., Chang, J. H., Kwok, Y., Perentesis, J., Perkins, S. M., Hill-Kayser, C., Zeina, W., Laack, N. N., Yock, T. I., & Gargollo, P. C. (2025). Assessing Acute and Long‐Term Toxicities of Proton Radiation Therapy in Pediatric Pelvic Tumors: Findings From the Pediatric Proton Consortium Registry. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31811

Vancouver

Almohtasib J, Indelicato DJ, Paulino AC, Mihalcik S, Lee J, Ermoian R, et al. Assessing Acute and Long‐Term Toxicities of Proton Radiation Therapy in Pediatric Pelvic Tumors: Findings From the Pediatric Proton Consortium Registry. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31811

BibTeX
@article{Almohtasib2025,
  author = {Almohtasib, Jamil and Indelicato, Daniel J and Paulino, Arnold C and Mihalcik, Stephen and Lee, Jae and Ermoian, Ralph and Chang, John Hah-Chih and Kwok, Young and Perentesis, John and Perkins, Stephanie M and Hill-Kayser, Christine and Zeina, Wael and Laack, Nadia N and Yock, Torunn I and Gargollo, Patricio C},
  title = {Assessing Acute and Long‐Term Toxicities of Proton Radiation Therapy in Pediatric Pelvic Tumors: Findings From the Pediatric Proton Consortium Registry},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31811}
}
Kostenlos starten →